Dr. Deehan holds a doctoral degree in molecular and cell biology from the University of California, Berkeley. Dr. Deehan is a molecular biologist by training and has spent the last decade guiding drug discovery and biomarker development by designing and building high-resolution molecular models of disease, and creating systems that find meaning in large-scale biological data.

Dr. Deehan joined InsideTracker in early 2022 to lead the science teams where she has implemented and scaled multiple programs. Most recently, Dr. Deehan led the innovation of adding three new biomarkers to InsideTracker’s blood panel—estradiol, progesterone, and thyroid-stimulating hormone.